Egypt's GASC receives offer in local vegoils tender - trade
Egypt's state grains buyer, the General Authority for Supply Commodities (GASC,) is seeking an unspecified quantity of vegetable oils
Reuters News - 11 Apr 2021
Alexandria Co for Pharmaceuticals & Chemical Industries (AXPH.CA)
Also known as: Alex Co. Pharma, Alexandria Pharmaceuticals
132.34 EGP -1.47-1.099%
Alex Co. Pharma Stock Price & Performance
Recommendation
-
Div Yield
11.004%
P/E (Last 12 Month)
3.655
Upside
-
Target Price (Mean)
-
Open
133.50 EGP
Previous Close
133.81 EGP
Turnover
245.16K EGP
EPS
36.606 EGP
Volume
1,849
Transactions
12
Market Cap
669.05M EGP
IPO Date
27-Feb-1995
Analyst Estimates
| EPS | Revenue | |
|---|---|---|
| Mean Estimate |  | |
| Smart Estimate | | |
| Predicted Surprise | | |
| Mean Chg % | | |
Starmine Models
StarMine provides a suite of proprietary alpha-generating analytics and models spanning sectors, regions, and markets.
| Bullish | |
|---|---|
| Value Momentum | |
| Intrinsic Valuation | |
| Relative Valuation | |
| Credit Risk - Smart Ratios | |
| Credit Risk- Text Mining | |
| Bearish | |
|---|---|
| Price Momentum | |
About Alexandria Co for Pharmaceuticals & Chemical Industries
Business Summary
Manufacture of generic drugs, dental cartridges, medicated adhesive tapes, plasters, surgical gloves and sterile gauze dressing,eye drops, vitamins and veterinary products.
Country of Incorporation
Ownership Type
Established In
1962
Primary Sector
Stock Listing
| ID | Stock Type | Currency | Exchange | Symbol |
|---|---|---|---|---|
| AXPH.CASE | Ordinary | EGP | Egypt SE | AXPH |
Contact details
Primary address
Building: Alexandria Co for Pharmaceuticals & Chemical Industries BuildingStreet: Gamila Abou Herid Road
Area: Al Awayed Area
P.O. Box: 21511
Country: Egypt
City: Alexandria
CONTACT
- Tel: +20 3-331-0224
- Tel: +20 3-331-2226
- Fax: +20 3-330-2221
- www.alexcopharma.net
Region
AlexandriaOwnership
Ownership
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Holding Concentrations
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Financials
Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing
Executives
Dr Abla Youssef Abdullah
Managing Director
Mr Mohammed Khalifa
Information Technology Director
Dr Mohammed Ashraf
Head of Marketing
Board Members
Dr Abla Youssef Abdullah
Chairperson and director representing Drug Holding Company
Dr Mohammed Hasan Suleiman Rabih
Director
Mr Saifuddine Ahmad Abdulmoati
Director
Company information provided by Refinitiv
Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).
Zawya Coverage
Dubai Ruler orders $3.81mln Ramadan bonus for taxi plate owners
UAE's Gulf Islamic Investments acquires residential development in London
Dubai's Neo Capital boosts portfolio with acquisition of $73mln US property
E-commerce spending in UAE, Saudi Arabia set to surge this Ramadan
Buying frenzy: UAE's Aldar villas sold out in 48 hours; Emaar sales hit $1.6bln in 3 months
Tuesday Outlook: Asian shares cautious; oil edges higher on tension in Mideast
Dollar languishes near three-week low; gold slides
Stock Market Data
Powered By Knowledge Direct